BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shrestha UK, Karimi O, Crusius JB, Zhou F, Wang Z, Chen Z, van Bodegraven AA, Xiao J, Morré SA, Wang H, Li J, Xia B. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:312-9. [PMID: 19714744 DOI: 10.1002/ibd.21059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yamamoto-Furusho JK, Peñaloza-Coronel A, Sánchez-Muñoz F, Barreto-Zuñiga R, Dominguez-Lopez A. Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis. Inflamm Bowel Dis 2011;17:680-1. [PMID: 20848495 DOI: 10.1002/ibd.21322] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
2 Shawki HA, Abo-hashem EM, Youssef MM, Shahin M, Elzehery R. PPARɣ2, aldose reductase, and TCF7L2 gene polymorphisms: relation to diabetes mellitus. J Diabetes Metab Disord. [DOI: 10.1007/s40200-021-00963-4] [Reference Citation Analysis]
3 Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease. World J Gastroenterol 2011; 17(2): 197-206 [PMID: 21245992 DOI: 10.3748/wjg.v17.i2.197] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
4 Chen Y. Perspectives of IBD China: Is Crohn's and Colitis Foundation Model a Solution to Health Care Issues for the Country? Inflamm Bowel Dis 2018;24:925-9. [PMID: 29688396 DOI: 10.1093/ibd/izy056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
5 Poliska S, Penyige A, Lakatos PL, Papp M, Palatka K, Lakatos L, Molnar T, Nagy L; Hungarian IBD Study Group. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort. Inflamm Bowel Dis 2012;18:472-9. [PMID: 21710534 DOI: 10.1002/ibd.21798] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
6 Dou X, Xiao J, Jin Z, Zheng P. Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia. Oncol Lett 2015;10:1259-66. [PMID: 26622660 DOI: 10.3892/ol.2015.3397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
7 Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta. 2011;1812:1007-1022. [PMID: 21382489 DOI: 10.1016/j.bbadis.2011.02.014] [Cited by in Crossref: 458] [Cited by in F6Publishing: 424] [Article Influence: 41.6] [Reference Citation Analysis]
8 Annese V, Rogai F, Settesoldi A, Bagnoli S. PPARγ in Inflammatory Bowel Disease. PPAR Res 2012;2012:620839. [PMID: 22997506 DOI: 10.1155/2012/620839] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
9 Mwinyi J, Grete-Wenger C, Eloranta JJ, Kullak-Ublick GA. The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course. PPAR Res 2012;2012:349469. [PMID: 22448164 DOI: 10.1155/2012/349469] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
10 Uddin MS, Kabir MT, Jakaria M, Mamun AA, Niaz K, Amran MS, Barreto GE, Ashraf GM. Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK. Neurotox Res 2019;36:583-601. [PMID: 31055770 DOI: 10.1007/s12640-019-00047-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
11 Zhang ZF, Yang N, Zhao G, Zhu L, Wang LX. Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis. PLoS One. 2012;7:e30551. [PMID: 22276212 DOI: 10.1371/journal.pone.0030551] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
12 Vázquez-Del Mercado M, Guzmán-Ornelas MO, Corona Meraz FI, Ríos-Ibarra CP, Reyes-Serratos EA, Castro-Albarran J, Ruíz-Quezada SL, Navarro-Hernández RE. The 482Ser of PPARGC1A and 12Pro of PPARG2 Alleles Are Associated with Reduction of Metabolic Risk Factors Even Obesity in a Mexican-Mestizo Population. Biomed Res Int 2015;2015:285491. [PMID: 26185753 DOI: 10.1155/2015/285491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
13 Ferguson LR. Nutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease? Front Immunol 2015;6:467. [PMID: 26441972 DOI: 10.3389/fimmu.2015.00467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
14 Neuman MG, Nanau RM. Single-nucleotide polymorphisms in inflammatory bowel disease. Transl Res 2012;160:45-64. [PMID: 22687962 DOI: 10.1016/j.trsl.2011.10.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
15 Chehaibi K, Nouira S, Mahdouani K, Hamdi S, Rouis M, Slimane MN. Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus. J Mol Neurosci 2014;54:730-8. [PMID: 24841086 DOI: 10.1007/s12031-014-0326-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
16 Guo C, Yao F, Wu K, Yang L, Zhang X, Ding J. Chromatin immunoprecipitation and association study revealed a possible role of Runt-related transcription factor 3 in the ulcerative colitis of Chinese population. Clin Immunol 2010;135:483-9. [PMID: 20392673 DOI: 10.1016/j.clim.2010.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]